BBNX.US Beta Bionics, Inc. Common Stock

Healthcare Health Care Equipment & Supplies USA Stocks
16.42 USD
Close of Nov 14, 2026
8.80 32.71
Market cap
USD 893M
P/E
-
P/B
2.23x
ROE
-23.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is BBNX.US undervalued?

Graham number

The Graham number of Beta Bionics, Inc. Common Stock cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Beta Bionics, Inc. Common Stock fundamental analysis

No fundamental analysis for Beta Bionics, Inc. Common Stock yet.

Beta Bionics, Inc. Common Stock stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Beta Bionics, Inc. Common Stock

Beta Bionics, Inc., a commercial-stage medical device company, engages in the design, development, and commercialization of solutions to enhance the health and quality of life of insulin-requiring people with diabetes. It offers iLet Bionic Pancreas, an insulin delivery device for the treatment of type 1 diabetes in adults and children six years of age and older. The company is also developing Patch Pump, an insulin pump that is designed to adhere directly to the skin and ad…

Full company profile